Article

CMS Extends Deadline to Appeal EHR Incentive Eligibility

Physicians and other so-called eligible professionals still wanting to appeal their eligibility determinations for the 2011 Medicare electronic health-record incentive payment program will have an extra month to file those appeals, the CMS announced.

The new deadline is April 30.

Read the full story: http://hcp.lv/HW1ouy

Source: ModernHealthcare

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!
Related Videos
Dr Sundar Jagannath
Michael Hassett, MD, MPH, Dana-Farber Cancer Institute
Senator Vincent Polistina (R, New Jersey)
Rebecca Chacko, MD.
1 expert in this video
Rebecca Chacko, MD, breast medical oncologist at Henry Ford
Amir Fathi, MD, Mass General
Related Content
Acne scar | Image credit: ZAY WIN HTAI - stock.adobe.com
July 24th 2025

Addressing Acne in Patients of Color

Pearl Steinzor
Culturally informed, patient-centered strategies are needed to address acne and hyperpigmentation in patients with skin of color.
managed care cast logo
July 24th 2025

High Costs, Coverage Variability Limit Access to Incretin Mimetics for Weight Management

Brooke McCormick Stephen Lott, PharmD, MS Jonathan Gabison, MD, DABOM
This Managed Care Cast episode explores how high costs and inconsistent insurance coverage for incretin mimetics impact obesity management and patient care.
FDA approval | Image Credit: Maggie-sora.chatgpt.com
July 24th 2025

FDA Approves Delgocitinib for Moderate to Severe Hand Eczema

Maggie L. Shaw
Adult patients with moderate to severe hand eczema with previous treatment failure or in whom topical corticosteroids are contraindicated stand to benefit the most from this approval.
Managed Care Cast
Published: July 15th 2025 | Updated: July 15th 2025

Navigating Risk, Treatment, and Reimbursement in Precision Oncology: Sadie Dobrozsi, MD

Giuliana Grossi Sadie Dobrozsi, MD, MS Interview by Mary Caffrey
Sadie Dobrozsi, MD, of Evolent, discusses how predictive genomics is pushing cancer care into a new era of personalization
Woman and child holding red ribbon | Image credit: ArvStd - stock.adobe.com
July 24th 2025

High Burdens of Drug Resistance Found in Children With HIV

Julia Bonavitacola
Mother-to-child transmission often led to pretreatment drug resistance and acquired drug resistance in children living with HIV.
The FDA has issued a complete response letter for RP1 plus nivolumab for advanced melanoma after a PD-1 inhibitor–containing regimen. | Image credit: ra2studio - stock.adobe.com
July 24th 2025

RP1 Plus Nivolumab Receives CRL for Advanced Melanoma

Chris Ryan
The CRL was given because the FDA did not consider the phase 1/2 IGNYTE trial to be an adequate and well-controlled clinical investigation to provide substantial evidence to support approval

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo